370 related articles for article (PubMed ID: 32481414)
1. Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients.
Eren T; Karacin C; Ucar G; Ergun Y; Yazici O; İmamoglu Gİ; Ozdemir N
Medicine (Baltimore); 2020 May; 99(22):e20346. PubMed ID: 32481414
[TBL] [Abstract][Full Text] [Related]
2. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
[TBL] [Abstract][Full Text] [Related]
3. Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.
Xu J; Ni C; Ma C; Zhang L; Jing X; Li C; Liu Y; Qu X
Clin Transl Oncol; 2017 Aug; 19(8):989-996. PubMed ID: 28247194
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
6. Neutrophils-to-lymphocytes, lymphocytes to-monocytes and platelets-to-lymphocytes ratios - predictive biomarkers for response to neoadjuvant chemotherapy in breast cancer.
Caziuc A; Schlanger D; Amarinei G; Dindelegan GC
J BUON; 2020; 25(1):182-187. PubMed ID: 32277630
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.
Wang H; Huang Z; Xu B; Zhang J; He P; Gao F; Zhang R; Huang X; Shan M
Clin Transl Oncol; 2024 Jun; 26(6):1467-1479. PubMed ID: 38190034
[TBL] [Abstract][Full Text] [Related]
8. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H
BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623
[TBL] [Abstract][Full Text] [Related]
9. Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study.
Zhao G; Chen J; Wang J; Wang S; Xia J; Wei Y; Wu J; Huang G; Chen F; Shi J; Lyu J; Liu C; Huang X
J Orthop Surg Res; 2020 Nov; 15(1):571. PubMed ID: 33256763
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.
Goto W; Kashiwagi S; Asano Y; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Hirakawa K; Ohira M
BMC Cancer; 2018 Nov; 18(1):1137. PubMed ID: 30453914
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
Dong J; Sun Q; Pan Y; Lu N; Han X; Zhou Q
BMC Cancer; 2021 Jun; 21(1):700. PubMed ID: 34126950
[TBL] [Abstract][Full Text] [Related]
12. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
[TBL] [Abstract][Full Text] [Related]
13. Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients.
Peng Y; Chen R; Qu F; Ye Y; Fu Y; Tang Z; Wang Y; Zong B; Yu H; Luo F; Liu S
Cancer Biol Ther; 2020; 21(2):189-196. PubMed ID: 31684807
[TBL] [Abstract][Full Text] [Related]
14. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke.
Gong P; Liu Y; Gong Y; Chen G; Zhang X; Wang S; Zhou F; Duan R; Chen W; Huang T; Wang M; Deng Q; Shi H; Zhou J; Jiang T; Zhang Y
J Neuroinflammation; 2021 Feb; 18(1):51. PubMed ID: 33610168
[TBL] [Abstract][Full Text] [Related]
15. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy.
Marín Hernández C; Piñero Madrona A; Gil Vázquez PJ; Galindo Fernández PJ; Ruiz Merino G; Alonso Romero JL; Parrilla Paricio P
Clin Transl Oncol; 2018 Apr; 20(4):476-483. PubMed ID: 28785911
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
18. A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer.
Van Berckelaer C; Van Geyt M; Linders S; Rypens C; Trinh XB; Tjalma WAA; Van Laere S; Colpaert C; Dirix L; van Dam PA
Breast; 2020 Oct; 53():212-220. PubMed ID: 32890963
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
[TBL] [Abstract][Full Text] [Related]
20. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer.
Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY
Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]